SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study evaluates whether daily SMS-based (text messages) symptom monitoring is feasible and acceptable in patients who are undergoing treatment for multiple myeloma (MM) or systemic light chain amyloidosis (AL), and whether it can help in early identification of symptoms that may require clinical attention.
Epistemonikos ID: 023dc55468b49033240a775cf341aaa62cd2cdc8
First added on: Oct 01, 2026